Half-year report · Q2
2590.TEDINET S100UB7G
Period2024-01-21 → 2024-07-20
Filed2024-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥117.6bn | 2024-01-21 → 2024-07-20 | Cons. | Net sales |
| Revenue | ¥213.4bn | 2023-01-21 → 2024-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.7bn | 2023-01-21 → 2023-07-20 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2024-01-21 → 2024-07-20 | Cons. | Operating income |
| Operating income | ¥2.5bn | 2023-01-21 → 2023-07-20 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2024-01-21 → 2024-07-20 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2023-01-21 → 2024-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2023-01-21 → 2023-07-20 | Cons. | Ordinary income |
| Profit before tax | ¥6.5bn | 2024-01-21 → 2024-07-20 | Cons. | Income before income taxes |
| Profit before tax | ¥4.1bn | 2023-01-21 → 2023-07-20 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.9bn | 2024-01-21 → 2024-07-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.4bn | 2023-01-21 → 2024-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2023-01-21 → 2023-07-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.7bn | 2024-01-21 → 2024-07-20 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2023-01-21 → 2023-07-20 | Cons. | Profit loss |
| Total assets | ¥199.3bn | at 2024-07-20 | Cons. | Assets |
| Total assets | ¥177.6bn | at 2024-01-20 | Cons. | Assets |
| Total assets | ¥182.1bn | at 2023-07-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥105.2bn | at 2024-07-20 | Cons. | Liabilities |
| Total liabilities | ¥86.1bn | at 2024-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥94.2bn | at 2024-07-20 | Cons. | Net assets |
| Net assets / equity | ¥91.5bn | at 2024-01-20 | Cons. | Net assets |
| Net assets / equity | ¥87.8bn | at 2023-07-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥36.5bn | at 2024-07-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.4bn | at 2024-01-20 | Cons. | Cash and deposits |
| Cash & equivalents | ¥36.3bn | at 2024-07-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.7bn | at 2024-01-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.0bn | at 2023-07-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.2bn | at 2023-01-20d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.5bn | 2024-01-21 → 2024-07-20 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2023-01-21 → 2023-07-20 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.1bn | 2024-01-21 → 2024-07-20 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.4bn | 2023-01-21 → 2023-07-20 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.8bn | 2024-01-21 → 2024-07-20 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥50m | 2023-01-21 → 2023-07-20 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥155.7 | 2024-01-21 → 2024-07-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.77 | 2023-01-21 → 2024-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.64 | 2023-01-21 → 2023-07-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.4% | at 2024-07-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2024-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.2% | at 2023-07-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-21 → 2024-07-20 | −¥167m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-21 → 2024-07-20 | −¥167m |
| Reconciling Itemsreconciling | segment profit | 2024-01-21 → 2024-07-20 | −¥674m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥73.0bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥73.0bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥17m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | −¥238m |
| jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segment | segment profit | 2024-01-21 → 2024-07-20 | −¥295m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥11.1bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥11.1bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥3m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | ¥899m |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥26.8bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥26.8bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | ¥2.3bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2024-01-21 → 2024-07-20 | ¥6.9bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2024-01-21 → 2024-07-20 | ¥6.7bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥146m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2024-01-21 → 2024-07-20 | ¥324m |
| —segment total | revenue | 2024-01-21 → 2024-07-20 | ¥117.7bn |
| —segment total | revenue external | 2024-01-21 → 2024-07-20 | ¥117.6bn |
| —segment total | revenue intersegment | 2024-01-21 → 2024-07-20 | ¥167m |
| —segment total | segment profit | 2024-01-21 → 2024-07-20 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-07-20 | −¥204m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-07-20 | −¥204m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-07-20 | −¥502m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥74.3bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥74.2bn |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥19m |
| jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥1.8bn |
| jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-07-20 | −¥296m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥10.8bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥10.8bn |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥3m |
| jpcrp040300-q2r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥776m |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥10.5bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥10.5bn |
| jpcrp040300-q2r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥462m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-07-20 | ¥6.4bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-07-20 | ¥6.2bn |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥180m |
| jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-07-20 | ¥239m |
| —segment total | revenue | 2023-01-21 → 2023-07-20 | ¥102.0bn |
| —segment total | revenue external | 2023-01-21 → 2023-07-20 | ¥101.7bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-07-20 | ¥204m |
| —segment total | segment profit | 2023-01-21 → 2023-07-20 | ¥3.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Cost of sales | CurrentYTDDuration | 63824000000 | JPY |
| Gross profit | Prior1YTDDuration | 47502000000 | JPY |
| Gross profit | CurrentYTDDuration | 53754000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 44975000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 51434000000 | JPY |
| Operating income | Prior1YTDDuration | 2527000000 | JPY |
| Operating income | CurrentYTDDuration | 2319000000 | JPY |
| Interest income noi | Prior1YTDDuration | 107000000 | JPY |
| Interest income noi | CurrentYTDDuration | 304000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 39000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 30000000 | JPY |
| Other noi | Prior1YTDDuration | 410000000 | JPY |
| Other noi | CurrentYTDDuration | 368000000 | JPY |
| Non operating income | Prior1YTDDuration | 557000000 | JPY |
| Non operating income | CurrentYTDDuration | 703000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 217000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 576000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 825000000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 467000000 | JPY |
| Loss on the net monetary position noe | Prior1YTDDuration | 5000000 | JPY |
| Loss on the net monetary position noe | CurrentYTDDuration | 339000000 | JPY |
| Other noe | Prior1YTDDuration | 262000000 | JPY |
| Other noe | CurrentYTDDuration | 244000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 1311000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 1626000000 | JPY |
| Ordinary income | Prior1YTDDuration | 1773000000 | JPY |
| Ordinary income | CurrentYTDDuration | 1396000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 2025000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 5133000000 | JPY |
| Insurance proceeds income ei | Prior1YTDDuration | 421000000 | JPY |
| Insurance proceeds income ei | CurrentYTDDuration | － | JPY |
| Extraordinary income | Prior1YTDDuration | 2447000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 5133000000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 82000000 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | － | JPY |
| Extraordinary loss | Prior1YTDDuration | 82000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | － | JPY |
| Income before income taxes | Prior1YTDDuration | 4138000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 6529000000 | JPY |
| Income taxes | Prior1YTDDuration | 1729000000 | JPY |
| Income taxes | CurrentYTDDuration | 1806000000 | JPY |
| Profit loss | Prior1YTDDuration | 2408000000 | JPY |
| Profit loss | CurrentYTDDuration | 4723000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 65000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | -182000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 2343000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 4905000000 | JPY |
| Profit loss | Prior1YTDDuration | 2408000000 | JPY |
| Profit loss | CurrentYTDDuration | 4723000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -455000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |